Skip to content

Author

Kang-Kang Liu

We have 2 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Isocyanate‐Modified Melatplatin(IV) Enhances Antitumor Efficacy via TCF4/COL6A3‐Mediated Extracellular Matrix Remodeling and cGAS‐STING Pathway Activation in Bladder Cancer

ABSTRACT Cisplatin (CDDP) chemosensitivity and severe toxicity severely limit its clinical application in muscle‐invasive bladder cancer (MIBC) and non‐muscle‐invasive bladder cancer (NMIBC). To address these unmet clinical needs, we synthesized a series of melatonin‐conjugated platinum(IV) prodrugs functionalized with...

Lin-Hui Wang, Xiao-Meng Liu, Tao Zhu et al. · 0 citations
Aug 2026

Biomimetic Phytic Acid–Metal–Albumin Nanocomplexes for Tumor-Selective, Bioclearable Theranostics

A biomimetic phytic acid–metal–albumin nanoternary complex is introduced that repurposes the body’s natural PA–metal–protein assembly/clearance axis to enable tumor-targeted theranostics and unifies imaging, therapy, and immune modulation, advancing precision oncology with strong translational potential.

Dengyi Duan, Jing Peng, Wen-Yi Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.